Virginia Mason Cancer Center is a clinical research site located in Seattle, Washington, United States 98111.
Crixeo Health Trust Score: 72/100 (FAIR). This profile has not yet been claimed by the site owner.
Virginia Mason Cancer Center has participated in 6 clinical trials.
Therapeutic areas: Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma.
Sponsors: Gilead Sciences, Celgene, Spectrum Pharmaceuticals, Inc.
Trust Score: 72/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Virginia Mason Cancer Center has a Crixeo Trust Score of 72/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Virginia Mason Cancer Center has 6 clinical trials on record. Their work covers Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma.
Yes — Virginia Mason Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.